BBP-818

N/A

Report date: 2024/11/15 11:25:20

Base Information

Drug NameBBP-818
Drug Alias NameBBP818
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGalactose-1-phosphate uridylyltransferase gene transference
TargetsGalactose-1-phosphate uridylyltransferase
Therapy Area/IndicationsGalactosemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBridgebio Pharma
China Registration ClassN/A

Develop Information

Active CompaniesBridgebio PharmaThe University Of Utah
Inactive CompaniesN/A
Active IndicationsGalactosemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A